Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Half Securon SR 120mg tablets
0206020T0BDAGAU
|
Securon | Verapamil hydrochloride | Cardiovascular System | 15,577 |
|
Securon SR 240mg tablets
0206020T0BDAEAH
|
Securon | Verapamil hydrochloride | Cardiovascular System | 10,235 |
|
Securon 120mg tablets
0206020T0BDACAF
|
Securon | Verapamil hydrochloride | Cardiovascular System | 10 |
|
Securon IV 5mg/2ml solution for injection ampoules
0206020T0BDAIAA
|
Securon | Verapamil hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.